-
UTime reaffirms leadership intact after unauthorized press releases
-
UTime reaffirms leadership after unauthorized SEC filing claims resignations
-
UTime receives Nasdaq deficiency notice on stockholders equity
-
UTime receives Nasdaq deficiency notice over equity requirement
-
UTime (WTO) announces 1-for-10 reverse stock split
-
Eweb21 Corp. (WTO) Announces 1:10 Reverse Share Split
-
Eweb21 Corp. (WTO) Prices 7.69M Share Offering at $0.65/sh
-
UTime Limited (WTO) Announces 1:25 Reverse Share Split
-
UTime (WTO) Signs NDA to Acquire Monkeypox Vaccine Maker Bowen Therapeutics Inc and Supports Completion of FDA Registration of Related Vaccines
-
Eweb21 Corp. (WTO) Regains Nasdaq Compliance

